4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)piperidine-4-carboxamide,
AZD5363,
AZD5363,
1143532-39-1,
capivasertib,
AZD-5363,
AZD 5363,
UNII-WFR23M21IE,
WFR23M21IE,
cc-638,
(S)-4-AMINO-N-(1-(4-CHLOROPHENYL)-3-HYDROXYPROPYL)-1-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE,
4-Amino-N-[(1s)-1-(4-Chlorophenyl)-3-Hydroxypropyl]-1-(7h-Pyrrolo[2,3-D]pyrimidin-4-Yl)piperidine-4-Carboxamide,
4-Piperidinecarboxamide, 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-,
C21H25ClN6O2,
4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinecarboxamide,
CHEMBL2325741,
Capivasertib (AZD5363),
MLS006011179,
SCHEMBL390243,
GTPL7709,
DTXSID40150710,
EX-A285,
JDUBGYFRJFOXQC-KRWDZBQOSA-N,
2241AH,
MFCD22628785,
s8019,
ZINC43204023,
AKOS027323693,
BCP9000365,
CS-1284,
DB12218,
PB18384,
RL00565,
NCGC00345795-01,
NCGC00345795-04,
BC600652,
HY-15431,
SMR004702948,
BCP0726000111,
A1387,
SW220158-1,
A11759,
Q-4064,
J-514447,
0XZ,
1143532-51-7,
D01ZAQ,
AZD5365,
AZD5363, 99%, a potent pan-AKT kinase inhibitor - 5MG 5mg,